Huldrych F Günthard
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque
Rotger M, Miró J, Palou E, Hoffmann M, Massanella M, Blanco J, Woods M, Günthard H, de Bakker P, Douek D, Silvestri G, Martinez-Picado J, Hirschel B, Fellay J, Erkizia I, Dalmau J, Rauch A, McLaren P, Bosinger S, Martinez R, Sandler N, Roque A, Liebner J, Battegay M, Bernasconi E, Descombes P, Telenti A. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest 2011; 121:2391-400.
May 9, 2011Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque
May 9, 2011J Clin Invest 2011; 121:2391-400
Rotger Margalida, Miró Jose M, Palou Eduard, Hoffmann Matthias, Massanella Marta, Blanco Julià, Woods Matthew, Günthard Huldrych F, de Bakker Paul, Douek Daniel C, Silvestri Guido, Martinez-Picado Javier, Hirschel Bernard, Fellay Jacques, Erkizia Itziar, Dalmau Judith, Rauch Andri, McLaren Paul, Bosinger Steven E, Martinez Raquel, Sandler Netanya G, Roque Annelys, Liebner Julia, Battegay Manuel, Bernasconi Enos, Descombes Patrick, Telenti Amalio
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors
Scherrer A, Günthard H, Ledergerber B, Bernasconi E, Vernazza P, Battegay M, Cavassini M, Hirschel B, Garzoni C, Bürgisser P, Klimkait T, Yerly S, Böni J, von Wyl V, Swiss HIV Cohort Study (SHCS). Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. J Acquir Immune Defic Syndr 2011; 57:24-31.
May 1, 2011Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors
May 1, 2011J Acquir Immune Defic Syndr 2011; 57:24-31
Scherrer Alexandra U, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Cavassini Matthias, Hirschel Bernard, Garzoni Christian, Bürgisser Philippe, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Swiss HIV Cohort Study (SHCS)
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance
di Iulio J, Rauch A, Telenti A, Klenerman P, Barnes E, Hirschel B, Schmid P, Bernasconi E, Battegay M, Günthard H, Furrer H, Pulit S, Martinez R, Fellay J, Rotger M, Kelleher D, Fitzmaurice K, Ciuffi A, Swiss HIV Cohort Study. Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology 2011; 53:1446-54.
May 1, 2011Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance
May 1, 2011Hepatology 2011; 53:1446-54
di Iulio Julia, Rauch Andri, Telenti Amalio, Klenerman Paul, Barnes Eleanor, Hirschel Bernard, Schmid Patrick, Bernasconi Enos, Battegay Manuel, Günthard Huldrych F, Furrer Hansjakob, Pulit Sara, Martinez Raquel, Fellay Jacques, Rotger Margalida, Kelleher Dermot, Fitzmaurice Karen, Ciuffi Angela, Swiss HIV Cohort Study
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection
Haas A, Oxenius A, Günthard H, Macpherson A, Patuto N, Vernazza P, Hirschel B, Battegay M, Thurnheer M, Weber R, Bossart W, Ledergerber B, Rusert P, Slack E, Graw F, Zimmermann K, Swiss HIV Cohort Study. Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut 2011; 60:1506-19.
Apr 21, 2011Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection
Apr 21, 2011Gut 2011; 60:1506-19
Haas Anna, Oxenius Annette, Günthard Huldrych F, Macpherson Andrew J, Patuto Nicola, Vernazza Pietro, Hirschel Bernard, Battegay Manuel, Thurnheer Maria C, Weber Rainer, Bossart Walter, Ledergerber Bruno, Rusert Peter, Slack Emma, Graw Frederik, Zimmermann Kathrin, Swiss HIV Cohort Study
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
Fehr J, Hirschel B, Vernazza P, Martinetti G, Bernasconi E, Günthard H, Battegay M, Bucher H, Klimkait T, Fux C, Cavassini M, Glass T, Louvel S, Hamy F, Hirsch H, von Wyl V, Böni J, Yerly S, Bürgisser P, Hiv Cohort Study A. Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study. J Transl Med 2011; 9:14.
Jan 21, 2011Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
Jan 21, 2011J Transl Med 2011; 9:14
Fehr Jan, Hirschel Bernard, Vernazza Pietro, Martinetti Gladys, Bernasconi Enos, Günthard Huldrych F, Battegay Manuel, Bucher Heiner C, Klimkait Thomas, Fux Christoph A, Cavassini Matthias, Glass Tracy R, Louvel Severine, Hamy Francois, Hirsch Hans H, von Wyl Viktor, Böni Jürg, Yerly Sabine, Bürgisser Philippe, Hiv Cohort Study And The Swiss
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy
Ortiz M, Tarr P, Telenti A, Günthard H, Ledergerber B, Cavassini M, Hirschel B, Vernazza P, Bernasconi E, Elzi L, Arnedo M, Martinez R, Kovari H, Furrer H, Poloni E, Swiss HIV Cohort Study. No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. J Infect Dis 2011; 203:620-4.
Jan 12, 2011No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy
Jan 12, 2011J Infect Dis 2011; 203:620-4
Ortiz Millán, Tarr Philip E, Telenti Amalio, Günthard Huldrych F, Ledergerber Bruno, Cavassini Matthias, Hirschel Bernard, Vernazza Pietro, Bernasconi Enos, Elzi Luigia, Arnedo Mireia, Martinez Raquel, Kovari Helen, Furrer Hansjakob, Poloni Estella S, Swiss HIV Cohort Study
Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection
Kouyos R, Cavassini M, Rauch A, Battegay M, Vernazza P, Bernasconi E, Ledergerber B, Bonhoeffer S, Günthard H, Hirschel B, Weber R, Klimkait T, von Wyl V, Yerly S, Böni J, Rieder P, Joos B, Taffé P, Shah C, Bürgisser P, Swiss HIV Cohort Study. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin Infect Dis 2011; 52:532-9.
Jan 10, 2011Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection
Jan 10, 2011Clin Infect Dis 2011; 52:532-9
Kouyos Roger D, Cavassini Matthias, Rauch Andri, Battegay Manuel, Vernazza Pietro, Bernasconi Enos, Ledergerber Bruno, Bonhoeffer Sebastian, Günthard Huldrych F, Hirschel Bernard, Weber Rainer, Klimkait Thomas, von Wyl Viktor, Yerly Sabine, Böni Jürg, Rieder Philip, Joos Beda, Taffé Patrick, Shah Cyril, Bürgisser Philippe, Swiss HIV Cohort Study
Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
Gianella S, Günthard H, Joos B, Weber R, Vernazza P, Hirschel B, Rauch A, Cavassini M, Bernasconi E, Battegay M, Niederoest B, Fischer M, von Wyl V, the Swiss HIV Cohort Study. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Antivir Ther 2011; 16:535-545.
Jan 1, 2011Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
Jan 1, 2011Antivir Ther 2011; 16:535-545
Gianella Sara, Günthard Huldrych F, Joos Beda, Weber Rainer, Vernazza Pietro, Hirschel Bernard, Rauch Andri, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Niederoest Barbara, Fischer Marek, von Wyl Viktor, the Swiss HIV Cohort Study
Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
Lubomirov R, Telenti A, Günthard H, Furrer H, Vernazza P, Elzi L, Bernasconi E, Hirschel B, Cavassini M, Martinez R, Ledergerber B, di Iulio J, Colombo S, the Swiss HIV Cohort Study. Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study. J Infect Dis 2010; 203:246-257.
Dec 9, 2010Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
Dec 9, 2010J Infect Dis 2010; 203:246-257
Lubomirov Rubin, Telenti Amalio, Günthard Huldrych F, Furrer Hansjakob, Vernazza Pietro, Elzi Luigia, Bernasconi Enos, Hirschel Bernard, Cavassini Matthias, Martinez Raquel, Ledergerber Bruno, di Iulio Julia, Colombo Sara, the Swiss HIV Cohort Study
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load
Alizon S, Bonhoeffer S, Günthard H, Telenti A, Bürgisser P, Battegay M, Bernasconi E, Vernazza P, Rauch A, Furrer H, Klimkait T, Shah C, Böni J, Hirschel B, Yerly S, Kouyos R, Stadler T, von Wyl V, Swiss HIV Cohort Study. Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog 2010; 6
Sep 30, 2010Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load
Sep 30, 2010PLoS Pathog 2010; 6
Alizon Samuel, Bonhoeffer Sebastian, Günthard Huldrych F, Telenti Amalio, Bürgisser Philippe, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Rauch Andri, Furrer Hansjakob, Klimkait Thomas, Shah Cyril, Böni Jürg, Hirschel Bernard, Yerly Sabine, Kouyos Roger D, Stadler Tanja, von Wyl Viktor, Swiss HIV Cohort Study
Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir
Gutmann C, Vernazza P, Yerly S, Cavassini M, Decosterd L, Hirschel B, Fux C, Günthard H, Cusini A, Swiss HIV Cohort Study (SHCS). Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir. AIDS 2010; 24:2347-54.
Sep 24, 2010Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir
Sep 24, 2010AIDS 2010; 24:2347-54
Gutmann Christine, Vernazza Pietro, Yerly Sabine, Cavassini Matthias, Decosterd Laurent-Arthur, Hirschel Bernard, Fux Christoph, Günthard Huldrych F, Cusini Alexia, Swiss HIV Cohort Study (SHCS)
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy
Rohrbach J, Rauch A, Klenerman P, Furrer H, Battegay M, Bernasconi E, Hoffmann M, Hirschel B, Günthard H, Keiser O, Telenti A, Gorgievski M, Gaudieri S, Hammond E, Harcourt G, Robinson N, Swiss HIV Cohort Study S. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Gut 2010; 59:1252-1258.
Jul 26, 2010Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy
Jul 26, 2010Gut 2010; 59:1252-1258
Rohrbach Janine, Rauch Andri, Klenerman Paul, Furrer Hansjakob, Battegay Manuel, Bernasconi Enos, Hoffmann Matthias, Hirschel Bernhard, Günthard Huldrych F, Keiser Olivia, Telenti Amalio, Gorgievski Meri, Gaudieri Silvana, Hammond Emma, Harcourt Gillian, Robinson Nicola, Swiss HIV Cohort Study SHCS
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland
Kouyos R, Bonhoeffer S, Ledergerber B, Rickenbach M, Bernasconi E, Vernazza P, Battegay M, Furrer H, Cavassini M, Hirschel B, Weber R, Klimkait T, Bürgisser P, Shah C, Taffé P, Böni J, Yerly S, von Wyl V, Günthard H. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. J Infect Dis 2010; 201:1488-97.
May 15, 2010Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland
May 15, 2010J Infect Dis 2010; 201:1488-97
Kouyos Roger D, Bonhoeffer Sebastian, Ledergerber Bruno, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Furrer Hansjakob, Cavassini Matthias, Hirschel Bernard, Weber Rainer, Klimkait Thomas, Bürgisser Philippe, Shah Cyril, Taffé Patrick, Böni Jürg, Yerly Sabine, von Wyl Viktor, Günthard Huldrych F
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Rauch A, Hirschel B, Malinverni R, Moradpour D, Mullhaupt B, Witteck A, Beckmann J, Berg T, Bergmann S, Negro F, Telenti A, Bochud P, Swiss Hepatitis C Cohort Study, Heim M, Günthard H, Furrer H, Kutalik Z, Descombes P, Cai T, di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour J, Swiss HIV Cohort Study. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010; 138:1338-45, 1345.e1-7.
Jan 11, 2010Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Jan 11, 2010Gastroenterology 2010; 138:1338-45, 1345.e1-7
Rauch Andri, Hirschel Bernard, Malinverni Raffaele, Moradpour Darius, Mullhaupt Beat, Witteck Andrea, Beckmann Jacques S, Berg Thomas, Bergmann Sven, Negro Francesco, Telenti Amalio, Bochud Pierre-Yves, Swiss Hepatitis C Cohort Study, Heim Markus, Günthard Huldrych F, Furrer Hansjakob, Kutalik Zoltán, Descombes Patrick, Cai Tao, di Iulio Julia, Mueller Tobias, Bochud Murielle, Battegay Manuel, Bernasconi Enos, Borovicka Jan, Colombo Sara, Cerny Andreas, Dufour Jean-François, Swiss HIV Cohort Study
Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study
Glass T, Bucher H, Günthard H, Rickenbach M, Bernasconi E, Hirschel B, Vernazza P, Furrer H, De Geest S, Cavassini M, Battegay M, the Swiss HIV Cohort Study. Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2009
Dec 23, 2009Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study
Dec 23, 2009Journal of acquired immune deficiency syndromes (1999) 2009
Glass Tracy R, Bucher Heiner C, Günthard Huldrych F, Rickenbach Martin, Bernasconi Enos, Hirschel Bernard, Vernazza Pietro, Furrer Hansjakob, De Geest Sabina, Cavassini Matthias, Battegay Manuel, the Swiss HIV Cohort Study
Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy
Cusini A, Günthard H, Weber R, Huber M, Kamarashev J, Bertisch B, Peter S, Beck B. Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy. BMJ Case Rep 2009; 2009
Dec 1, 2009Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy
Dec 1, 2009BMJ Case Rep 2009; 2009
Cusini Alexia, Günthard Huldrych F, Weber Rainer, Huber Milo, Kamarashev Jivko, Bertisch Barbara, Peter Silke, Beck Bernhard
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland
von Wyl V, Günthard H, Ledergerber B, Bonhoeffer S, Francioli P, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Bürgisser P, Yerly S, Swiss HIV Cohort Study. Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:979-87.
Apr 1, 2009Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland
Apr 1, 2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:979-87
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Bonhoeffer Sebastian, Francioli Patrick, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Yerly Sabine, Swiss HIV Cohort Study
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir
von Wyl V, Günthard H, Ledergerber B, Rickenbach M, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Bürgisser P, Böni J, Yerly S, Swiss HIV Cohort Study. Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 46:1299-309.
Apr 15, 2008Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir
Apr 15, 2008Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 46:1299-309
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Rickenbach Martin, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Böni Jürg, Yerly Sabine, Swiss HIV Cohort Study
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types
von Wyl V, Günthard H, Ledergerber B, Perrin L, Rickenbach M, Bernasconi E, Vernazza P, Hirschel B, Telenti A, Furrer H, Battegay M, Klimkait T, Bürgisser P, Böni J, Yerly S, for the Swiss HIV Cohort Study. Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Archives of internal medicine 2007; 167:1782-90.
Sep 10, 2007Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types
Sep 10, 2007Archives of internal medicine 2007; 167:1782-90
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Perrin Luc, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Telenti Amalio, Furrer Hansjakob, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Böni Jürg, Yerly Sabine, for the Swiss HIV Cohort Study
Stable virulence levels in the HIV epidemic of Switzerland over two decades
Müller V, Bonhoeffer S, Günthard H, Vernazza P, Bernasconi E, Telenti A, Furrer H, Klimkait T, Perrin L, Ledergerber B, Swiss HIV Cohort Study. Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS (London, England) 2006; 20:889-94.
Apr 4, 2006Stable virulence levels in the HIV epidemic of Switzerland over two decades
Apr 4, 2006AIDS (London, England) 2006; 20:889-94
Müller Viktor, Bonhoeffer Sebastian, Günthard Huldrych F, Vernazza Pietro, Bernasconi Enos, Telenti Amalio, Furrer Hansjakob, Klimkait Thomas, Perrin Luc, Ledergerber Bruno, Swiss HIV Cohort Study